These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9924185)
1. Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. Jessop DS J Endocrinol; 1999 Feb; 160(2):169-80. PubMed ID: 9924185 [No Abstract] [Full Text] [Related]
2. Peptides of the central nervous system. Klee WA Adv Protein Chem; 1979; 33():243-86. PubMed ID: 94507 [No Abstract] [Full Text] [Related]
3. Gaseous neurotransmitter modulation of vasopressin and oxytocin release. Forsling ML; Grossman A Adv Exp Med Biol; 1998; 449():191-2. PubMed ID: 10026804 [No Abstract] [Full Text] [Related]
4. The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Engler D; Redei E; Kola I Endocr Rev; 1999 Aug; 20(4):460-500. PubMed ID: 10453355 [No Abstract] [Full Text] [Related]
5. Role of the hypothalamic pituitary adrenal axis in the control of the response to stress and infection. McCann SM; Antunes-Rodrigues J; Franci CR; Anselmo-Franci JA; Karanth S; Rettori V Braz J Med Biol Res; 2000 Oct; 33(10):1121-31. PubMed ID: 11004712 [TBL] [Abstract][Full Text] [Related]
6. Clinical and experimental studies on the role of GABA in the regulation of ACTH secretion: a review. Jones MT; Gillham B; Altaher AR; Nicholson SA; Campbell EA; Watts SM; Thody A Psychoneuroendocrinology; 1984; 9(2):107-23. PubMed ID: 6147872 [No Abstract] [Full Text] [Related]
7. Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. Buckingham JC; Flower RJ Mol Med Today; 1997 Jul; 3(7):296-302. PubMed ID: 9257297 [TBL] [Abstract][Full Text] [Related]
8. [Interactions between the immune system and the neuroendocrine system. Implications of the hypothalamo-hypophyseal-adrenal axis]. Sandi C; Castro-Alamancos MA; Cambronero JC; Bailón C; Guaza C; Borrel J Arch Neurobiol (Madr); 1989; 52(6):277-86. PubMed ID: 2534566 [TBL] [Abstract][Full Text] [Related]
9. Regulation of stress-induced secretion of POMC-derived peptides. Van Loon GR; De Souza EB Ann N Y Acad Sci; 1987; 512():300-7. PubMed ID: 2831779 [No Abstract] [Full Text] [Related]
11. The role of endogenous opioid systems in neuroendocrine regulation. Risch SC; Janowsky DS; Judd LL; Gillin JC; McClure SF Psychiatr Clin North Am; 1983 Sep; 6(3):429-41. PubMed ID: 6139793 [No Abstract] [Full Text] [Related]
12. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. Mancuso C; Navarra P; Preziosi P J Neurochem; 2010 May; 113(3):563-75. PubMed ID: 20089135 [TBL] [Abstract][Full Text] [Related]
13. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat. Yamauchi N; Shibasaki T; Wakabayashi I; Demura H Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422 [TBL] [Abstract][Full Text] [Related]
14. Neuroscience for the neurosurgeon: The neuropeptides and behavior. Sweet WH; Smith BH Neurosurgery; 1978; 2(1):62-9. PubMed ID: 28495 [No Abstract] [Full Text] [Related]
17. Possible involvement of central atrial natriuretic polypeptide in regulation of hypothalamo-pituitary-adrenal axis in conscious rats. Itoh H; Nakao K; Katsuura G; Morii N; Yamada T; Shiono S; Sakamoto M; Sugawara A; Saito Y; Eigyo M Neurosci Lett; 1986 Sep; 69(3):254-8. PubMed ID: 2945127 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress. Gadek-Michalska A; Bugajski J J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770 [TBL] [Abstract][Full Text] [Related]
19. [Regulation of the hypothalamo-pituitary-adrenocortical axis from the aspect of its monitoring using a pharmacological approach]. Jezová-Repceková D Cesk Fysiol; 1977 Nov; 26(5):405-20. PubMed ID: 202408 [No Abstract] [Full Text] [Related]
20. [Peptide neuroregulators in the central nervous system]. Lutz W; Chmielewski H; Pawlak J Neurol Neurochir Pol; 1984; 18(1):43-50. PubMed ID: 6203045 [No Abstract] [Full Text] [Related] [Next] [New Search]